Align Technology Inc. stock (US0162551016): shares jump after strong one-day move while valuation stays in focus

Align Technology Inc. shares on the Nasdaq in the United States moved notably higher on 05/28/2026, with the stock price rising 6.4 percent to close at USD 173.25, according to a report on recent trading activity by GuruFocus as of 05/28/2026.GuruFocus as of 05/28/2026 This move puts fresh attention on the US-based orthodontics specialist, which is listed on Nasdaq under the ticker ALGN and forms part of the broader US growth universe of medical-technology stocks.

The same GuruFocus snapshot notes that Align Technology’s shares traded within a 52-week range over the past year, with the closing level of USD 173.25 on 05/28/2026 positioning the stock closer to the mid-range of that corridor rather than at an extreme.GuruFocus as of 05/28/2026 For investors following US-listed equities, the latest daily move stands out against the broader market and keeps the focus on how the company’s fundamentals and valuation might evolve into the next set of quarterly earnings figures. In Germany, the stock also trades via off-exchange venues such as Tradegate, where it is quoted in euro alongside its primary USD listing, offering an additional access point for European investors tracking the US name.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

Align Technology Inc.: core business model

Align Technology primarily develops and markets clear aligner systems and digital dental-scanning solutions, generating most of its revenue from orthodontists and general dental practices that adopt its Invisalign-branded treatments and related software workflows.

Valuation metrics and multiples for Align Technology Inc.

The recent one-day price move leaves the valuation of Align Technology framed by its current market capitalization and earnings profile, which market data providers track using indicators such as the price-earnings ratio and enterprise-value-based measures. Nasdaq’s listing information for ALGN shows the company as a mid- to large-cap US medical-technology name, and common valuation approaches compare its multiples with those of other dental and broader medtech peers to gauge relative pricing.Nasdaq ALGN overview as of 05/29/2026 Investors also follow measures such as the price-to-sales ratio and free-cash-flow yields, particularly because Align Technology does not currently emphasize a regular cash dividend, and returns are therefore mainly driven by capital gains and any share repurchase activity that may be disclosed in company filings.

An additional reference point comes from institutional portfolio data, which shows Align Technology held in various US-focused funds that use fundamental and quantitative screens.SP Funds data as of 2026 Inclusion in such portfolios can influence trading volumes and, by extension, the valuation multiples at which the stock trades when flows shift into or out of US growth and health-care-related strategies. While detailed real-time multiples change with the share price and updated earnings information, the latest trading level near USD 173 on 05/28/2026 serves as a concrete anchor point for ongoing valuation discussions.

Conclusion

The sharp gain in Align Technology’s share price on 05/28/2026 underscores how quickly sentiment on the Nasdaq-listed dental-technology group can shift when investors adjust expectations for growth or risk. With the stock now trading around the mid-point of its 52-week range and valuation metrics in focus, market participants are likely to watch upcoming financial disclosures and sector trends closely to see whether the current pricing of the US orthodontics specialist remains justified. Against that backdrop, both the daily price action and evolving comparative multiples will shape how the stock is positioned within broader US and international portfolios.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.